Related Experiment Videos
[Bacterial endocarditis due to Staphylococcus epidermidis. Two cases (author's transl)].
Summary
Staphylococcus epidermidis endocarditis is a rare but severe condition. Successful treatment involved tailored antibiotic regimens and, in one case, prosthetic valve replacement.
Area of Science:
- Infectious Diseases
- Cardiology
- Microbiology
Context:
- Bacterial endocarditis caused by Staphylococcus epidermidis is infrequently encountered but associated with significant morbidity.
- Prosthetic valve endocarditis presents unique challenges in diagnosis and management.
- Co-existing conditions, such as liver disease and corticosteroid use, can influence patient susceptibility and treatment outcomes.
Purpose:
- To report two rare cases of bacterial endocarditis caused by Staphylococcus epidermidis.
- To describe the clinical presentation, treatment strategies, and outcomes in patients with Staphylococcus epidermidis endocarditis.
- To highlight the complexities in managing prosthetic valve endocarditis.
Summary:
- The first case involved a 58-year-old male with a double prosthetic valve (mitral and aortic) who developed endocarditis 40 days post-surgery. Treatment with vancomycin and gentamicin, followed by pristinamycin and tobramycin, achieved a cure.
- The second case concerned a 50-year-old female with cirrhogenic hepatitis and on corticosteroids, who developed endocarditis without an identifiable source. Despite various antibiotic combinations, surgical intervention with mitral Starr valve replacement was necessary for cure.
- Neither patient exhibited signs of valvular damage or prosthesis dislodgement.
Impact:
- This case series underscores the importance of considering Staphylococcus epidermidis in prosthetic valve endocarditis, even in rare instances.
- It demonstrates the potential efficacy of specific antibiotic combinations and the critical role of surgical intervention in refractory cases.
- The findings contribute to the understanding of managing severe endocarditis in complex patient populations.